SAMSARA BIOCAPITAL
Samsara Biocapital, LLC provides investment advisory services.
SAMSARA BIOCAPITAL
Social Links:
Industry:
Financial Services
Founded:
2016-09-23
Status:
Active
Contact:
1-650-285-4270
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Cash App
Cash App is the fastest growing financial brand in the world.
Northpond Ventures
Northpond Ventures is a science-driven project capital ๏ฌrm that focuses on biotechnology and a๏ฌliated industries.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Walden International
Walden International is a venture capital firm that specializes in a wide range of funding and investment for industries.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Autobahn Therapeutics | Samsara BioCapital investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
| 2022-07-18 | Delfi Diagnostics | Samsara BioCapital investment in Series B - Delfi Diagnostics | 225 M USD |
| 2022-06-29 | MiroBio | Samsara BioCapital investment in Series B - MiroBio | 80 M GBP |
| 2022-06-17 | Scholar Rock | Samsara BioCapital investment in Post-IPO Equity - Scholar Rock | 205 M USD |
| 2022-06-08 | Mineralys Therapeutics | Samsara BioCapital investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-06-07 | ImmunOs Therapeutics | Samsara BioCapital investment in Series B - ImmunOs Therapeutics | 71 M CHF |
| 2022-06-02 | Upstream Bio | Samsara BioCapital investment in Series A - Upstream Bio | 200 M USD |
| 2022-04-08 | Lyra Therapeutics | Samsara BioCapital investment in Post-IPO Equity - Lyra Therapeutics | 100.5 M USD |
| 2022-02-22 | Eyebiotech | Samsara BioCapital investment in Series A - Eyebiotech | 65 M USD |
| 2022-02-09 | Seismic Therapeutic | Samsara BioCapital investment in Series A - Seismic Therapeutic | 101 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-05 | ElevateBio Appoints Kareem Reda as Chief Business Officer |
More informations about "Samsara BioCapital"
Samsara BioCapital - Crunchbase Investor Profile
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies. Samsara BioCapital, as a results-driven organization, is always looking for ambitious and visionary โฆ See details»
Samsara BioCapital investment portfolio - PitchBook
Samsara BioCapital's latest investment was on 02-Jun-2025 in SpyGlass Pharma, a company within the Surgical Devices industry. Data Transparency. Meet our data hygiene team. Discover how our โฆ See details»
Samsara BioCapital - LinkedIn
Samsara BioCapital | 2,922 followers on LinkedIn. At Samsara BioCapital, we partner with scientists and entrepreneurs to translate cutting-edge science into transformative medicines for patients. See details»
Samsara BioCapital โ Info, Investments & Portfolio - Gilion
Samsara BioCapital is a venture capital firm dedicated to supporting entrepreneurs in the medical field. With years of experience in both the medical and investment industries, the firm aims to โฆ See details»
Samsara BioCapital - Investor in Palo Alto, California - Ask For Funding
Samsara BioCapital was founded after years of working in the medical field and investment industry. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies with โฆ See details»
Investors - Autobahn Labs
Samsara BioCapital is a new breed of biotech investment fund focused on translating cutting-edge biology into new therapies to treat patients with unmet medical needs. Founded in 2016 by Srinivas Akkaraju, MD, PhD, our team of โฆ See details»
Team - Samsara Biocapital
Samsara Biocapital helping entrepreneurs turn their ideas into successful companies. See details»
Samsara BioCapital - BIO International Convention 2025
Our sponsors help support BIO's mission to support and advocate for the biotechnology industry. See details»
Samsara BioCapital | Institution Profile | Private Equity International
Samsara BioCapital. News, insights, analysis and data. Samsara BioCapital overview. Founded in 2016, Samsara Bio Capital was a California-based investment firm that focused on biotech โฆ See details»
Samsara BioCapital - vcinvestorlist.com
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies. Number of Investments: 143 Number of Exits: 62 โฆ See details»
Samsara BioCapital - Investments, Portfolio & Company Exits
Samsara BioCapital has made 41 diversity investments. Their most recent diversity investment was on Mar 24, 2025, when Surrozen raised. obfuscated. obfuscated. Announced Date . Organization โฆ See details»
Samsara BioCapital - Investor Profile, Portfolio, Investments & Team
Samsara BioCapital was founded after years of working in the medical field and investment industry. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies with โฆ See details»
Samsara BioCapital - Private Equity List
Samsara BioCapital was founded after years of working in the medical field and investment industry. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies with โฆ See details»
Samsara Biocapital targets $500m for fund - Venture Capital Journal
Jan 4, 2021 Samsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing. Iris Dorbian - 4 January 2021. Share A-A + 100%. Samsara Biocapital is seeking to โฆ See details»
Portfolio Companies - Samsara Biocapital
IO Biotech (IOBT) is a clinical-stage biopharmaceutical company pioneering the discovery and development of novel and highly differentiated immune-oncology therapeutics based on its โฆ See details»
Samsara BioCapital Portfolio Companies - Crunchbase
Feb 5, 2015 Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies. This list of organizations invested in by โฆ See details»
Our Culture - Samsara Biocapital
The culture at Samsara BioCapital is critical to our shared vision to have a significant impact on the lives of patients. We recognize that we accomplish this only indirectly, but we feel incredibly โฆ See details»
Samsara BioCapital - Private Equity List
At Samsara BioCapital, we partner with scientists and entrepreneurs to translate cutting-edge science into transformative medicines for patients. We feel incredibly fortunate to invest during a โฆ See details»
Samsara BioCapital - Contacts, Employees, Board Members
Samsara BioCapital has 5 current employee profiles, including Venture Partner Marcos Milla. Samsara BioCapital has 1 board member or advisor, John Curnutte. Contacts. Edit Contacts โฆ See details»
Samsara Reports First Quarter Fiscal Year 2026 Financial Results
1 day ago Samsara Reports First Quarter Fiscal Year 2026 Financial Results Q1 revenue of $366.9 million, representing 31% year-over-year growth or 32% year-over-year growth adjusted for โฆ See details»